Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions

Catherine L Auriemma; Maayra I Butt; Jasmine A Silvestri; Scott D Halpern; Katherine R Courtright

doi:10.1001/jamainternmed.2023.0918

Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions

JAMA Intern Med. 2023 Jul 1;183(7):739-742. doi: 10.1001/jamainternmed.2023.0918.

Authors

Catherine L Auriemma^{1

2

3}, Maayra I Butt¹, Jasmine A Silvestri¹, Scott D Halpern^{1

2

3}, Katherine R Courtright^{1

2

3}

Affiliations

¹ Palliative and Advanced Illness Research Center, University of Pennsylvania School of Medicine, Philadelphia.
² Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
³ Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

No abstract available

Plain language summary

This survey study examined perceptions of patients, caregivers and health care professionals on the number of hospital-free days required for detection of a minimum clinically important difference or noninferiority margin of new interventions.

Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions

Authors

Affiliations

Plain language summary

Publication types

MeSH terms

Grants and funding